Translational research. New findings and potential future applications in pancreatic adenocarcinoma

Journal of the Pancreas

Volumn 13, Issue 2, 2012, Pages 177-179

  Strimpakos, Alexios S ^a   Syrigos, Kostas N ^a   Saif, Muhammad Wasif ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b New York Presbyterian Hospital ^*  (United States)

Author keywords

Adenocarcinoma; Biological markers; Gemcitabine; Pancreatic neoplasms

Indexed keywords

CALVASCULIN; FLUOROURACIL; GEMCITABINE; MICRORNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RESISTANCE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFICACY; HUMAN; PANCREAS ADENOCARCINOMA; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYMPOSIUM; TRANSLATIONAL RESEARCH;

ADENOCARCINOMA; HUMANS; PANCREATIC NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 84858681134     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Strimpakos AS, Syrigos KN, Saif MW. The molecular targets for the diagnosis and treatment of pancreatic cancer. Gut Liver 2010 Dec,4(4), 433-449.
2. Schultz NA, Dehlendorff C, Werner J, et al. Diagnostic microRNA serum profile in pancreatic cancer. J Clin Oncol (Meeting Abstracts) 2012 Jan 30,30(4_suppl), 160.
3. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004 Mar 2,101(9), 2999-3004.
4. Javle MM, Tan D, Li Y, et al. Transforming growth factor (TGF) beta pathway and clinical outcome of pancreatic cancer. J Clin Oncol (Meeting Abstracts) 2012 Jan 30,30(4_suppl), 201.
5. Bierie B, Moses HL. TGF-beta and cancer. Cytokine Growth Factor Rev 2006 Feb,17(1-2), 29-40.
6. Tempero MA, Moughan J, Kim GE, et al. S100A4 as a biomarker of resistance to gemcitabine: A secondary analysis of RTOG 9704. J Clin Oncol (Meeting Abstracts) 2012 Jan 30,30(4_suppl), 165.
7. Mahon PC, Baril P, Bhakta V, et al. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 2007 Jul 15,67(14), 6786-6795.